Federal contract award
75N95023F00001
PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. TO1 PHASE 1 COCAINE DRUG INTERACTION SEPTEMBER 25, 2023 TO MARCH 24, 2025. N01DA-23-893
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | 75N95023D00019 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.8M |
| Current contract value | $1.8M |
| Potential contract value / ceiling | $1.8M |
| Start date | Sep 25, 2023 |
| Current end date | Oct 22, 2025 |
| Potential end date | Oct 22, 2025 |
| Latest award activity | Jun 4, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 4, 2026 | P00003 | $-0 | PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. TO1 PHASE 1 COCAINE DRUG INTERACTION SEPTEMBER 25, 2023 TO OCTOBER 22, 2025. N01DA-23-8935 |
| Jul 23, 2025 | P00002 | $0 | PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. TO1 PHASE 1 COCAINE DRUG INTERACTION SEPTEMBER 25, 2023 TO OCTOBER 22, 2025. N01DA-23-8935 |
| Mar 13, 2025 | P00001 | $0 | PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. TO1 PHASE 1 COCAINE DRUG INTERACTION SEPTEMBER 25, 2023 TO JULY 23, 2025. N01DA-23-893 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.